Dr Reddys Laboratories (RDY) Operating Expenses (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Operating Expenses of $292.0 million for Q2 2023, up 6.96% quarter-over-quarter from $273.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Operating Expenses (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Operating Expenses history runs 15 years deep, the most recent figure standing at $292.0 million for Q2 2023.
- In Q2 2023, Operating Expenses changed N/A year-over-year to $292.0 million; the TTM figure through Mar 2026 stood at $292.0 million (down 48.32% YoY), while the FY2026 annual figure was $1.4 billion, down 2.74% from the prior year.
- Operating Expenses for Q2 2023 stood at $292.0 million, up from $273.0 million in the prior quarter.
- The five-year high for Operating Expenses was $292.0 million in Q2 2023, with the low at $278.0 in Q3 2022.
- The 5-year median for Operating Expenses is $246.5 million (2020), against an average of $233.3 million.
- The sharpest annual moves came in 2019 and 2021: Operating Expenses retreated 0.89% in 2019, then climbed 15.79% in 2021.
- Dr Reddys Laboratories' Operating Expenses stood at $233.0 million in 2019, then gained by 8.58% to $253.0 million in 2020, then grew by 8.7% to $275.0 million in 2021, then grew by 3.27% to $284.0 million in 2022, then gained by 2.82% to $292.0 million in 2023.
- Business Quant data shows RDY's Operating Expenses at $292.0 million in Q2 2023, $273.0 million in Q1 2023, and $284.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 477.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 292.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 284.00 Mn |
| Sep 30, 2022 | 278.00 |
| Jun 30, 2021 | 275.00 Mn |
| Mar 31, 2021 | 264.00 Mn |
| Sep 30, 2020 | 253.00 Mn |
| Jun 30, 2020 | 240.00 Mn |
| Mar 31, 2020 | 228.00 Mn |
| Sep 30, 2019 | 233.00 Mn |
| Jun 30, 2019 | 236.00 Mn |
| Mar 31, 2019 | 222.00 Mn |
| Dec 31, 2018 | 242.00 Mn |
| Sep 30, 2018 | 227.00 Mn |
| Jun 30, 2018 | 229.00 Mn |
| Mar 31, 2018 | 224.00 Mn |
| Dec 31, 2017 | 239.00 Mn |
| Sep 30, 2017 | 257.00 Mn |
| Dec 31, 2016 | 254.00 Mn |
| Sep 30, 2016 | 250.00 Mn |